GGRCX
Price
$14.78
Change
-$0.53 (-3.46%)
Updated
Dec 18 closing price
RGAEX
Price
$73.93
Change
-$9.65 (-11.55%)
Updated
Dec 18 closing price
Ad is loading...

GGRCX vs RGAEX

Header iconGGRCX vs RGAEX Comparison
Open Charts GGRCX vs RGAEXBanner chart's image
Goldman Sachs Strategic Growth C
Price$14.78
Change-$0.53 (-3.46%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R4
Price$73.93
Change-$9.65 (-11.55%)
VolumeN/A
CapitalizationN/A
GGRCX vs RGAEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GGRCX vs. RGAEX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGRCX is a StrongBuy and RGAEX is a Hold.

FUNDAMENTALS
Fundamentals
RGAEX has more cash in the bank: 313B vs. GGRCX (208M). RGAEX pays higher dividends than GGRCX: RGAEX (0.44) vs GGRCX (0.00). GGRCX was incepted earlier than RGAEX: GGRCX (26 years) vs RGAEX (23 years). GGRCX is a more actively managed with annual turnover of: 33.00 vs. RGAEX (31.00). RGAEX has a lower initial minimum investment than GGRCX: RGAEX (250) vs GGRCX (1000). GGRCX annual gain was more profitable for investors over the last year : 29.71 vs. RGAEX (19.06). RGAEX return over 5 years is better than : 47.36 vs. GGRCX (1.31).
GGRCXRGAEXGGRCX / RGAEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years23 years-
Gain YTD28.84618.835153%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets208M313B0%
Annual Yield % from dividends0.000.44-
Returns for 1 year29.7119.06156%
Returns for 3 years8.145.16158%
Returns for 5 years1.3147.363%
Returns for 10 years-50.1374.91-67%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COLL30.02-0.88
-2.85%
Collegium Pharmaceutical
IDA108.79-3.33
-2.97%
IDACORP
GIS63.91-2.02
-3.06%
General Mills
AMLX3.94-0.34
-7.94%
Amylyx Pharmaceuticals
WLGS2.03-0.30
-12.88%
Wang & Lee Group